Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Manman Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capita…. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Liver Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
It is essential to identify the subgroup of patients who experience poorer outcomes in order to adapt clinical management effectively. In the context of liver disease, the earlier the identification occurs, the greater the range of therapeutic options that can be offered to patients. In the past, patients with acute decompensation (AD) of chronic liver disease were treated as a homogeneous group, with emphasis on identifying those at the highest risk of death. In the last 15 years, a differentiation has emerged between acute‐on‐chronic liver failure syndrome (ACLF) and AD, primarily due to indications that the latter is linked to a less favorable short‐term prognosis. Nevertheless, the definition of ACLF varies among the different knowledge societies, making it challenging to assess its true impact compared with AD. Therefore, the purpose of this review is to provide a detailed analysis emphasizing the critical importance of identifying ACLF in the field of advanced liver disease. We will discuss the differences between Eastern and Western approaches, particularly in relation to the occurrence of liver failure and disease onset. Common characteristics, such as the dynamic nature of the disease course, will be highlighted. Finally, we will focus on two key clinical implications arising from these considerations: the prevention of ACLF before its onset and the clinical management strategies once it develops, including liver transplantation and withdrawal of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital, Medical University, Beijing, China.
- Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, China.
- Institute of Liver Studies, King's College Hospital, London, UK.
- Liver Disease Department, Rennes University Hospital, Rennes, France.
- Rennes University and Inserm NuMeCan UMR 1317, Rennes, France.
ORCID-Profile: Florent Artru
Zitieren
APA
Xu, M., Chen, Y., & Artru, F. (2024). Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12538
Vancouver
Xu M, Chen Y, Artru F. Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12538
BibTeX
@article{Xu2024,
author = {Xu, Manman and Chen, Yu and Artru, Florent},
title = {Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12538}
}
EUVIMED